Kane Biotech Announces Third Quarter 2021 Financial Results
November 16, 2021 16:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), today announced their third quarter 2021 financial results. ...
Kane Biotech to Release Third Quarter 2021 Financial Results on November 16 – Conference Call to Follow
November 09, 2021 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech Announces New Credit Facility
September 02, 2021 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announces that it has entered into an amended and restated...
STEM Animal Health completes first shipment of bluestem™ oral care products to PetSmart® Canada
August 31, 2021 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces that STEM Animal Health Inc., has shipped its first order of bluestem™ products to PetSmart® Canada, Canada largest...
Kane Biotech Announces Second Quarter 2021 Financial Results
August 26, 2021 16:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its Second Quarter 2021 financial results. Second...
Kane Biotech to Release Second Quarter 2021 Financial Results on August 26 – Conference Call to Follow
August 19, 2021 16:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech Receives Decisions to Grant for Two European Patents Providing Broad Protection of coactiv+™ Technology for Wound Care, Skin Infections and Personal Care Formulations
July 29, 2021 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, July 29, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces that it has received two Decisions to Grant from the European Patent Office for patents covering its best-in-class...
Kane Biotech Expands its Wound Care and Surgical Portfolio with a coactiv+TM Antimicrobial Hydrogel
July 22, 2021 08:00 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, July 22, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. announces plans to expand its wound care and surgical portfolio with an antimicrobial hydrogel based on its best-in-class...
Kane Biotech Announces Cancellation of Options and Issuance of Restricted Share Units
July 21, 2021 16:30 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, July 21, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announces that it has cancelled 8,470,555 stock options of...
Kane Biotech announces two key milestones as DispersinB® wound care project advances towards human clinical trials
July 13, 2021 08:00 ET
|
Kane Biotech Inc.
Development of a novel topical hydrogel formulation of DispersinB® with significantly improved stabilityNew manufacturing partnership with Dow Development Laboratories, LLC for clinical product...